Inventor · disambiguated record
Aprile L. Pilon
Also filed as: PILON APRILE · PILON APRILE L
13 granted patents·15 pending applications·73 citations·filing 1997–2020
91Inventor score
Top patents by PatentIndex Score
28 records- 0193US7846899B2Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary diseaseCLARASSANCE INC·Filed 2008·Granted Dec 7, 2010·15 cites·6 claims
- 0288US8470767B2Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary diseasePILON APRILE L·Filed 2010·Granted Jun 25, 2013·6 cites·10 claims
- 0385US9394349B2Modification and compositions of human secretoglobin proteinsCLARASSANCE INC·Filed 2013·Granted Jul 19, 2016·5 cites·180 claims
- 0480US11512121B2Compositions and methods of use for recombinant human secretoglobinsAPC RES ASSETS LLC·Filed 2020·Granted Nov 29, 2022·1 cites·4 claims
- 0580US9765127B2Compositions and methods of use for recombinant human secretoglobinsTHERABRON THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·3 cites·6 claims
- 0677US10556938B2Compositions and methods of use for recombinant human secretoglobinsTHERABRON THERAPEUTICS INC·Filed 2017·Granted Feb 11, 2020·2 cites·5 claims
- 0776US6660271B2Ubiquitin fusion-based vaccine systemPROTEINIX COMPANY·Filed 2001·Granted Dec 9, 2003·7 cites·16 claims
- 0866US8957018B2Recombinant human CC10 protein for treatment of influenzaPILON APRILE L·Filed 2010·Granted Feb 17, 2015·2 cites·7 claims
- 0965US2013261047A1Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary diseasePILON APRILE L·Filed 2013·Application pending·0 cites
- 1061US7122344B2Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditionsCLARAGEN INC·Filed 2001·Granted Oct 17, 2006·6 cites·16 claims
- 1160US7662642B2Method for detection of specific antibodies using ubiquitin fusion proteinsWELLSTAT BIOCATALYSIS LLC·Filed 2003·Granted Feb 16, 2010·0 cites·4 claims
- 1257US6255281B1Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditionsCLARAGEN INC AND U S GOVERNMEN·Filed 1997·Granted Jul 3, 2001·14 cites·10 claims
- 1356US2010183640A1Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte productionPILON APRILE L·Filed 2009·Application pending·0 cites
- 1456US2006281681A1Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary diseasePILON APRILE L·Filed 2006·Application pending·0 cites
- 1555US2014274915A1Methods of Use for Recombinant Human SecretoglobinsCLARASSANCE INC·Filed 2013·Application pending·0 cites
- 1654US2008064633A1Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditionsPILON APRILE L·Filed 2007·Application pending·0 cites
- 1752US2009029917A1Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte productionPILON APRILE L·Filed 2008·Application pending·0 cites
- 1851US6319503B1Heat shock fusion-based vaccine systemPROTEINIX COMPANY·Filed 1998·Granted Nov 20, 2001·12 cites·17 claims
- 1948US2011240012A1Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitisCLARASSANCE INC·Filed 2010·Application pending·0 cites
- 2048US2005261180A1Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditionsPILON APRILE L·Filed 2003·Application pending·0 cites
- 2147US9168285B2Recombinant human CC10 protein for treatment of influenza and ebolaTHERABRON INC·Filed 2015·Granted Oct 27, 2015·0 cites·12 claims
- 2245US2006025348A1Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte productionPILON APRILE L·Filed 2005·Application pending·0 cites
- 2342US2002169108A1Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte productionFiled 2001·Application pending·0 cites
- 2441US2003207795A1Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditionsFiled 2002·Application pending·0 cites
- 2541US2002173460A1Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditionsCLARAGEN INC·Filed 2001·Application pending·0 cites
- 2636US2004047857A1Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte productionFiled 2003·Application pending·0 cites
- 2733US2003008816A1Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte productionFiled 2001·Application pending·0 cites
- 2827US2002160948A1Recombinant human uteroglobin in treatment of inflammatory and fibrotic conditionsFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →